Connect with us

Emerging Markets

Darkpulse Inc (OTCMKTS: DPLS) Major Reversal Brewing as Global Leader in Advanced Laser-Based Monitoring Systems Acquires Nasdaq SPAC GLEE

Published

8 months ago

on

Darkpulse Inc (OTCMKTS: DPLS) is heating up after the Company announced it has closed the acquisition of an equity position in Gladstone Acquisition Corp., a Delaware corporation (NASDAQ: GLEE) (the “SPAC”). Pursuant to the Purchase Agreement with Gladstone Sponsor, LLC, and the SPAC, the Company purchased 2,623,120 shares of Class B Common Stock and 4,298,496 Private Placement Warrants, each of which is exercisable to purchase one share of Class A Common Stock from the Original Sponsor, for $1,500,000. GLEE management has resigned and DPLS officer Geoff Mullins, Wayne Bale, and John Bartrum were appointed as members of the board of directors of the Company. Finally, Rick Iler was appointed as Principal Executive Officer, Chief Financial Officer and Secretary of the Company. In addition to the payment of the Purchase Price, the Company also assumed all responsibility for all of SPAC’s public company reporting obligations. For a long time Darkpulse has been planning to spin off Optilan onto a major exchange and the acquisition of GLEE is the perfect choice. They can now do an initial business combination and an intial public offering and raise a significant amount of money to fund expansion by  IPO’ing Optilan into GLEE with the bulk of OS in the new Company owned by DPLS shareholders via the Optilan dividend. 

DPLS continues to see record growth recently reporting record revenues in Q2, 2022 of $4,435,043, an increase of over 120% from the $2,018,333 reported in the previous quarter. Driving the sales increase was continued strong global demand for fiber and infrastructure sales for Optilan, as well as increases in revenue from the Company’s other subsidiaries. Continuing strong demand in the major markets in North America and Europe drove increased sales at Optilan by more than 118% and the Company’s U.S. subsidiaries increased by a combined total of more than 131% from the previous quarter. Management states they expect the latter half of 2022 to continue increasing revenues, with additional contracts wins through Q3 continuing throughout Q4 2022.  The Company just held its 2nd annual shareholders event and you can find it here.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Darkpulse Inc (OTCMKTS: DPLS) operating out of New York, develops, markets, and distributes a suite of engineering, installation, and security management solutions to industries and governments on an international level. DarkPulse’s ultra-high sensitivity infrastructure monitoring provides enhanced visibility to enterprises, allowing them to detect corrosion and system weaknesses before leaks, spills, and other tragic losses. Our system outperforms all other distributed fiber sensors in the market. The company intends to deliver security and monitoring systems in applications for border security, pipelines, the oil and gas industry, and mine safety. In addition to their leadership in sensing systems, DarkPulse is continuing to expand its offerings into services, and growing their suite of solutions to address global critical resource and infrastructure challenges. 

The Company’s recently acquired subsidiary Optilan is a global provider of turnkey telecommunications and security systems, and integration services intended to offer one-stop-shop services for all aspects of security and communication applications. The company’s services include design, installation, commissioning, support, and maintenance services of satellite, wireless, fiber transmission systems, CCTV security and radio-based systems, enabling the energy, transportation, critical infrastructure and industrial sectors to receive individually tailored, innovative applications and services that deliver value, resilience and flexibility. Optilan is headquartered in the United Kingdom and operates offices in Azerbaijan, India, the Middle East, UAE and Turkey. 

DPLS subsidiary TJM West Electronics is an ISO9001 and AS9100 certified electronics and electro-mechanical assembly operation operating out of a high tech, 20,000 Sq ft facility in Tempe, Arizona. The Company’s subsidiary Wildlife Specialists, LLC was founded in 2007 to provide clients with comprehensive wildlife and environmental assessment, planning, and monitoring services. The Company currently maintain two regional offices located in north central and southeastern Pennsylvania. 

In this videobotda - Twitter Search / Twitter engineers demonstrate the function of the dark-pulse based BOTDA system measuring strain on a PVC pipe. A 4″ PVC pipe specimen with 12′ length has a sensing fibre helically wrapped around it which measures the hoop strain as the pressure in the pipe is raised. Data is first collected at an internal pressure of 10 psig. The engineers then clamp one end of the pipe creating a disturbance in the strain field. This disturbance is readily seen in the second measurement demonstrating dark-pulse BOTDA system’s ability to detect sub-metre strain events. DarkPulse offers multiple configurations with increased processor capacity for faster data display including a cloud-based GUI as part of 24/7 structural health monitoring solutions. Darkpulse is a leader in distributed fiber sensor solutions. DPLS system outperforms all other distributed fiber sensors in the market today. DarkPulse’s growing list of world-class capabilities and the Company’s positioning as the leader in infrastructure sensing and monitoring in all domains, air, land, and sea which represents an enormous market worth billions puts Darkpulse in line for serious government contracts according to many investors who are buying in here. The Company continues to grow fast through acquisition. 

To Find out the inside Scoop on DPLS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

DPLS

The Company has been very busy; in August Optilan reported it has once again secured three contracts within the same week. The first two are related to the Oil & Gas Industry and located in Iraq and Qatar, respectively. A third contract was won for an offshore wind project located in the United States. The Company anticipates completion of all three contracts in roughly six months. The contract values total approximately USD $3M. Optilan has also successfully continued expansion of its Fibre and Emergency Response Services business unit. 

The Company also entered into agreements to increase its equity ownership to 100% in both Remote Intelligence, Limited Liability Company and Wildlife Specialists, LLC, which, when closed, will make both firms wholly owned subsidiaries of the Company. Together, both companies offer fully integrated, drone-based, geo-rectified, 3D modeled mapping for industrial applications specializing in the energy and environmental survey service. Initially specializing in the Oil & Gas industry, the companies will expand offerings into the home drone delivery markets. 

On October 13 DPLS announced it has closed the acquisition of an equity position in Gladstone Acquisition Corp., a Delaware corporation (NASDAQ: GLEE) (the “SPAC”). Pursuant to the Purchase Agreement with Gladstone Sponsor, LLC, and the SPAC, the Company purchased 2,623,120 shares of Class B Common Stock and 4,298,496 Private Placement Warrants, each of which is exercisable to purchase one share of Class A Common Stock from the Original Sponsor, for $1,500,000. 

David Gladstone, Terry L. Brubaker, Paul W. Adelgren, Michela A. English, John H. Outland, Anthony W. Parker, and Walter H. Wilkinson, Jr. tendered their resignations as officers and directors of the Company, Michael Malesardi, Michael LiCalsi, Bill Frisbie and Bill Reiman resigned as officers of the Company, and Geoff Mullins, Wayne Bale, and John Bartrum were appointed as members of the board of directors of the Company. Finally, Rick Iler was appointed as Principal Executive Officer, Chief Financial Officer and Secretary of the Company. 

In addition to the payment of the Purchase Price, the Company also assumed the following obligations: (i) responsibility for all of SPAC’s public company reporting obligations, (ii) the right to provide an extension payment and extend the deadline of the SPAC to complete an initial business combination from 15 months from August 9, 2021 to 18 months for an additional $1,150,000, and (iii) all other obligations and liabilities of the Original Sponsor related to the SPAC. 

For More on DPLS Subscribe Right Now!

Currently trading at a $113 million market valuation DPLS OS is 6,145,852,186. The Company has a strong balance sheet with $34 million in assets vs. $17 million in total liabilities including just $2 million in notes payable. DPLS has been working on some major projects in recent months including the Honcut Bridge in Loma Rica California, and recently signed a contract for the installation of its patented BOTDA EREBOS™ high resolution sensor system into Moon Land Resort in Hurghada Egypt. DPLS assisted with the launch of the world’s first intelligent bridge in Marysville, CA by installing its sensor technology with the California Division of Transportation (“CALTRANS”). DPLS is the Platinum sponsor for Smart Cities Connect Washington D.C Smart Cities conference to be held September 26th-29th and its CEO will be the keynote speaker. They also signed a MOU for the purchase of Om Optel Industries Pvt. Ltd., a fiber optic cable manufacturing business located in India. DPLS has completed a number of important acquisitions and expects to continue to see a reduction in costs with increases in revenues as it consolidates and adds key acquisitions in the near future. DPLS has runner in its blood skyrocketing out of the double zeroes last year to highs of $0.202 per share and investors are looking for a move back to these levels. Darkpulse continues to make big moves with the $15 million Company share buyback and the acquisition of Optilan which secured leases for two new facilities located in Warwickshire in the U.K as well as over a dozen new contracts including a contract for $45 million since the Company completed the acquisition. Investors in the Company have been waiting for a catalyst to end the downtrend that has decimated the share price since DPLS hit highs of $0.204 back in July 2021 and this just might be it with DPLS already up over 10% on the news in late trading Thursday. From current levels, DPLS has a lot ton of room for growth. We will be updating on DPLS when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in DPLS either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

5 days ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

2 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

3 weeks ago

on

May 14, 2023

By

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.